NLRP3 and chronic kidney disease: In chronic kidney disease (CKD) models, the myokine Irisin ameliorated palmitic acid-induced muscle atrophy by inhibiting fatty acid oxidation and the subsequent NLRP3 inflammasome activation and pyroptosis (Zhou et al., 2023).